Literature DB >> 9157242

Integration host factor stimulates both FimB- and FimE-mediated site-specific DNA inversion that controls phase variation of type 1 fimbriae expression in Escherichia coli.

I C Blomfield1, D H Kulasekara, B I Eisenstein.   

Abstract

The site-specific DNA inversion that controls phase variation of type 1 fimbriation in E. coli is catalysed by two recombinases, FimB and FimE. Efficient inversion by either recombinase also requires the leucine-responsive regulatory protein (Lrp). In addition, FimB recombination is stimulated by the integration host factor (IHF). The effect of IHF on FimE inversion has not previously been reported. Here it is shown that IHF stimulates FimE recombination; In strain MG1655, mutants containing lesions in either the alpha (ihfA) or beta (ihfB) subunits of IHF show a marked decrease in both FimB- (100-fold) and FimE (15,000-fold)-promoted switching. IHF is shown to bind with high affinity to sites both adjacent to (site I) and within (site II) the fim invertible element. Furthermore, mutations in site I or site II that lower the affinity of IHF binding In vitro were found to lower the frequency of FimE and/ or FimB recombination in vivo. Although site I and site II mutations in combination have an effect on FimB-promoted switching comparable to that of IHF knockout mutations (100-fold), the cis site mutations have a much less marked effect (100-fold) on FimE-promoted switching.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9157242     DOI: 10.1046/j.1365-2958.1997.2241615.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  35 in total

1.  Type 1 fimbriation and phase switching in a natural Escherichia coli fimB null strain, Nissle 1917.

Authors:  B Stentebjerg-Olesen; T Chakraborty; P Klemm
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

2.  Variable lipoprotein genes of Mycoplasma agalactiae are activated in vivo by promoter addition via site-specific DNA inversions.

Authors:  Ravenna Flitman-Tene; Sigalit Mudahi-Orenstein; Sharon Levisohn; David Yogev
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

3.  Modulation of the sensitivity of FimB recombination to branched-chain amino acids and alanine in Escherichia coli K-12.

Authors:  Maryam Lahooti; Paula L Roesch; Ian C Blomfield
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

4.  DNA supercoiling and the Lrp protein determine the directionality of fim switch DNA inversion in Escherichia coli K-12.

Authors:  Arlene Kelly; Colin Conway; Tadhg O Cróinín; Stephen G J Smith; Charles J Dorman
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

Review 5.  A complex transcription network controls the early stages of biofilm development by Escherichia coli.

Authors:  Birgit M Prüss; Christopher Besemann; Anne Denton; Alan J Wolfe
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

6.  Type 1 fimbriation and its phase switching in diarrheagenic Escherichia coli strains.

Authors:  K Iida; Y Mizunoe; S N Wai; S Yoshida
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

7.  complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli.

Authors:  M Chelsea Lane; Amy N Simms; Harry L T Mobley
Journal:  J Bacteriol       Date:  2007-05-18       Impact factor: 3.490

8.  Fur Represses Adhesion to, Invasion of, and Intracellular Bacterial Community Formation within Bladder Epithelial Cells and Motility in Uropathogenic Escherichia coli.

Authors:  Kumiko Kurabayashi; Tomohiro Agata; Hirofumi Asano; Haruyoshi Tomita; Hidetada Hirakawa
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

Review 9.  Escherichia coli biofilms.

Authors:  C Beloin; A Roux; J M Ghigo
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

10.  Self-perpetuating epigenetic pili switches in bacteria.

Authors:  Aaron Hernday; Margareta Krabbe; Bruce Braaten; David Low
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.